Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis

被引：0
作者：
Xin Tracy Liu
Yu Huang
Da Liu
Yingxin Celia Jiang
Min Zhao
Long Hoa Chung
Xingxing Daisy Han
Yinan Zhao
Jinbiao Chen
Paul Coleman
Ka Ka Ting
Collin Tran
Yingying Su
Claude Vincent Dennis
Atul Bhatnagar
Ken Liu
Anthony Simon Don
Mathew Alexander Vadas
Mark Douglas Gorrell
Shubiao Zhang
Michael Murray
Mary Meltem Kavurma
Geoffrey William McCaughan
Jennifer Ruth Gamble
Yanfei Qi
机构：
[1] The University of Sydney,Centenary Institute of Cancer Medicine and Cell Biology
[2] University of the Sunshine Coast,School of Science, Technology and Engineering
[3] Dalian Minzu University,Key Laboratory of Biotechnology and Bioresources Utilization of Ministry of Education
[4] The University of Sydney,School of Medical Sciences, Faculty of Medicine and Health
[5] The University of Sydney,Sydney Microscopy and Microanalysis
[6] Royal Prince Alfred Hospital,AW Morrow Gastroenterology and Liver Centre
[7] Sydney Local Health District,Sydney Mass Spectrometry
[8] The University of Sydney,Sydney Pharmacy School, Faculty of Medicine and Health
[9] The University of Sydney,undefined
[10] Heart Research Institute,undefined
来源：
Journal of Translational Medicine | / 22卷
关键词：
Sphingosine kinase; PF-543; PFKFB3; Angiogenesis; Glycolysis; Hepatocellular carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 341 条
[1]  
Rumgay H(2022)Global burden of primary liver cancer in 2020 and predictions to 2040 J Hepatol 77 1598-301
[2]  
Arnold M(2011)HCC and angiogenesis: possible targets and future directions Nat Rev Clin Oncol 8 292-630
[3]  
Ferlay J(2019)Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy J Hematol Oncol 12 27-89
[4]  
Lesi O(2019)Molecular and histological correlations in liver cancer J Hepatol 71 616-401
[5]  
Cabasag CJ(2020)Angiogenesis in hepatocellular carcinoma; pathophysiology, targeted therapy, and role of imaging J Hepatocell Carcinoma 7 77-946
[6]  
Vignat J(2021)Hepatocellular carcinoma Nat Rev Dis Primers 7 6-934
[7]  
Zhu AX(2022)Molecular pathogenesis and systemic therapies for hepatocellular carcinoma Nat Cancer 3 386-951
[8]  
Duda DG(2019)The metabolic engine of endothelial cells Nat Metab 1 937-663
[9]  
Sahani DV(2022)AGA clinical practice guideline on systemic therapy for hepatocellular carcinoma Gastroenterology 162 920-985
[10]  
Jain RK(2022)AGA technical review on systemic therapies for hepatocellular carcinoma Gastroenterology 162 937-433
12345678910